Search research articles
Contact Us
Filters
Showing results (211-220 of 282) with videos related to
Page
of 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen
Andrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.
European Urology
|
October 25, 2016
Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category
Ian D Davis, Wanling Xie, Carmel Pezaro, et al.
The Lancet. Oncology
|
February 22, 2014
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial
Robert J Motzer, Camillo Porta, Nicholas J Vogelzang, et al.
Journal of Surgical Oncology
|
May 24, 2018
Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis
Thomas Ahn, Robert J Ellis, Victoria M White, et al.
European Urology
|
October 22, 2022
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al.
Clinical Genitourinary Cancer
|
January 8, 2026
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)
Audreylie Lemelin, Martin Zarba, Kosuke Takemura, et al.
Clinical Genitourinary Cancer
|
June 23, 2026
Pembrolizumab and Denosumab in Clear-Cell Renal-Cell Carcinoma
Carole A Harris, Danka S Zebic, Michelle F Morris, et al.
BJU International
|
July 17, 2021
'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501)
Dickon Hayne, Jeremy Grummet, David Espinoza, et al.
BJU International
|
November 21, 2023
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma
Ciara Conduit, Ian D Davis, Jeffrey C Goh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2005
Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma
Geoffrey Chong, Fook Thean Lee, Wendie Hopkins, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 282) with videos related to
Sort By:
Page
of 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen
Andrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.
European Urology
|
October 25, 2016
Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category
Ian D Davis, Wanling Xie, Carmel Pezaro, et al.
The Lancet. Oncology
|
February 22, 2014
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial
Robert J Motzer, Camillo Porta, Nicholas J Vogelzang, et al.
Journal of Surgical Oncology
|
May 24, 2018
Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis
Thomas Ahn, Robert J Ellis, Victoria M White, et al.
European Urology
|
October 22, 2022
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al.
Clinical Genitourinary Cancer
|
January 8, 2026
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)
Audreylie Lemelin, Martin Zarba, Kosuke Takemura, et al.
Clinical Genitourinary Cancer
|
June 23, 2026
Pembrolizumab and Denosumab in Clear-Cell Renal-Cell Carcinoma
Carole A Harris, Danka S Zebic, Michelle F Morris, et al.
BJU International
|
July 17, 2021
'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501)
Dickon Hayne, Jeremy Grummet, David Espinoza, et al.
BJU International
|
November 21, 2023
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma
Ciara Conduit, Ian D Davis, Jeffrey C Goh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2005
Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma
Geoffrey Chong, Fook Thean Lee, Wendie Hopkins, et al.
Page
of 29